Morning Overview on MSN
New bowel cancer approach keeps disease at bay for 3 years
Every patient enrolled in a groundbreaking rectal cancer trial has remained disease-free for more than three years after ...
Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy ...
Neoadjuvant radiotherapy followed by surgery can improve overall survival compared with surgery alone in certain patients with locally advanced rectal cancers, most notably in those with lower rectal ...
Long-term survival and treatment efficacy in dMMR/MSI-H rectal cancer: A real-world cohort from seven large medical college–affiliated hospitals. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Colorectal cancers are the third-leading cause of cancer-related deaths for men and fourth for women, but is the second overall when men and women are combined, according to data compiled by the ...
PHILADELPHIA (WPVI) -- There is a clinical trial going on that hopes to change the way patients with early-stage colorectal cancer are treated. Fox Chase Cancer Center is investigating a method ...
Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the reason we lost the ...
Janine Stellacci is an avid runner who eats healthy, and has never smoked. Despite that, she was diagnosed with rectal cancer in 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results